Clinical Research Directory
Browse clinical research sites, groups, and studies.
Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Summary
This study aims to clarify the preventive effect of perioperative liraglutide application on postoperative delirium in elderly patients with Type 2 diabetes undergoing cardiac surgery.
Official title: Perioperative Application of Liraglutide for the Prevention of Postoperative Delirium Among Elderly Patients with Type 2 Diabetes Undergoing Cardiac Surgery: a Single-Center Randomized Controlled Study
Key Details
Gender
All
Age Range
60 Years - Any
Study Type
INTERVENTIONAL
Enrollment
260
Start Date
2024-11-19
Completion Date
2028-03-31
Last Updated
2024-12-20
Healthy Volunteers
No
Conditions
Interventions
Liraglutide injection
Subcutaneous injection of liraglutide: 0.6 mg administered the day before surgery, 1.8 mg administered post-anesthesia induction on the day of surgery, followed by 0.6 mg daily for the first three postoperative days.
Placebo injection
Subcutaneous injection of Placebo: the same volume as liraglutide administrated at the corresponding times.
Locations (1)
Wenxue liu
Nanjing, Jiangsu, China